ISCHAEMIA-MODIFIED ALBUMINM MEASURED AS A BIOMARKER IN EARLY DIAGNOSIS OF THE ACUTE CORONARY SYNDROME

ISCHEMIA MODIFIED ALBUMIN IS A SENSITIVE MARKER OF MYOCARDIAL ISCHEMIA AFTER PERCUTANEOUS CORONARY INTERVENTION

Diagnostic value of ''ischemia modified albumin'' in early detection of myocardial injury in acute coronary syndromes

Ischemia Modified Albumin, Serum Uric Acid and Serum Albumin as a Biomarkers of Oxidative Stress in Acute Ischemic Stroke

CARDIAC BIOMARKER PROFILING IN EVALUATION OF RISK IN ACUTE CORONARY SYNDROME

Ischemia-Modified Albumin in Cord Blood of Preterm Infants: A Novel Indicator for Intrauterine Growth Restriction- A Prospective Case Control Study.

The role of Ischemia modified albumin in detecting diabetic nephropathy

The utility of biomarkers in the discrimination of acute coronary syndrome patients

Ischemic Modified Albumin as A Biomarker in Predicting Oxidative Stress in Patients With Acne Vulgaris

ASSESSMENT OF THE ROLE OF SERUM ISCHEMIA MODIFIED ALBUMIN IN THE EARLY DIAGNOSIS OF NEONATAL SEPSIS